Kawasaki, Japan

Yoshitomo Chujo


Average Co-Inventor Count = 6.9

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1999-2007

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Yoshitomo Chujo

Introduction

Yoshitomo Chujo is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of pharmaceuticals and biotechnology. With a total of 3 patents, his work focuses on innovative compounds and vaccines that have the potential to impact public health.

Latest Patents

Chujo's latest patents include a range of inventive subject matter. One of his notable inventions is related to heterocyclic compounds. This patent involves pharmaceutical compositions and kits containing a heterocyclic compound represented by a specific formula. The compound includes an alkyl group and an amino group, among other components, as an active ingredient. Another significant patent is for an anti-AIDS secretory recombinant BCG vaccine. This vaccine utilizes Mycobacterium bovis BCG, which secretes a fusion protein obtained by inserting a foreign antigen peptide into a secretory protein. This innovative approach enhances the vaccine's antigenicity and immunogenicity, making it a promising candidate for effective immunization.

Career Highlights

Throughout his career, Yoshitomo Chujo has worked with prominent companies such as Ajinomoto Co., Ltd. and the National Institute of Health in Japan. His experience in these organizations has contributed to his expertise in developing groundbreaking pharmaceutical solutions.

Collaborations

Chujo has collaborated with notable colleagues, including Kazuhiro Matsuo and Akihiro Yamazaki. These partnerships have fostered a collaborative environment that encourages innovation and the advancement of scientific research.

Conclusion

Yoshitomo Chujo's contributions to the fields of pharmaceuticals and biotechnology highlight his role as an influential inventor. His innovative patents and collaborations demonstrate his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…